EP1596713A1 - Microcapteur de pression arterielle et appareil de mesure l`utilisant - Google Patents
Microcapteur de pression arterielle et appareil de mesure l`utilisantInfo
- Publication number
- EP1596713A1 EP1596713A1 EP04713570A EP04713570A EP1596713A1 EP 1596713 A1 EP1596713 A1 EP 1596713A1 EP 04713570 A EP04713570 A EP 04713570A EP 04713570 A EP04713570 A EP 04713570A EP 1596713 A1 EP1596713 A1 EP 1596713A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pressure
- arterial
- microsensor
- patient
- wave
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6838—Clamps or clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
- A61B5/02125—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/6804—Garments; Clothes
- A61B5/6806—Gloves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
Definitions
- the invention relates to an arterial pressure microsensor usable for establishing a cardiovascular risk factor criterion.
- It also relates to an arterial stiffness measuring device using such microsensors.
- Cardiovascular disease remains the number one killer in developed countries and is fast becoming the number one killer worldwide.
- cardiovascular risk factors have been identified during longitudinal follow-up studies, notably in North America (Framingham Heart Study).
- the main risk factors are age, gender, hypercholesterolemia, high blood pressure, diabetes, smoking.
- there are many other biological risk factors such as hyperhomocysteinemia, chronic inflammation: CRP, heavy metal levels, •••), socio-economic (level of education, profession, place of house, ).
- the parameters of structure and function of the large arteries are the most promising "integrative" risk factors.
- the two factors for which there are the most arguments at present are the intima media thickness of the primitive carotid artery, which will not be discussed here, and the rigidity of the large arteries.
- the large arteries close to the heart, have the property of deforming during related pressure changes to heart contraction.
- the proportionality ratio between deformation and deforming force corresponds to arterial stiffness.
- the physiological role of arterial elasticity (rigidity) is very important. Indeed, the elasticity of the large arteries serves as a diastolic relay for heart contraction.
- the heart only contracts during a third of the cycle (systole).
- the potential energy given to the blood during systole is transmitted in the form of elastic deformation to the wall of the large arteries, which restore it during diastole, thereby contributing to blood circulation.
- the stiffness of the arteries increases with age, as well as with most of the cardiovascular risk factors currently identified.
- the speed of the pulse wave (transit time of the pressure wave between two arterial sites, conventionally the primary carotid artery at the neck and the common femoral artery at the crease of the groin) is the the oldest known, and the best validated of all arterial stiffness parameters. It has been possible to demonstrate recently that the speed of the pulse wave predicted the onset of ischemic heart disease and cardiovascular mortality, independently and beyond prediction conferred by conventional risk factors.
- the analysis of the carotid pressure wave also makes it possible to obtain interesting hemodynamic parameters.
- Pulse wave velocity was used as an index of arterial distensibility by Bramwell and Hill in 1922, and since then by many authors.
- the relationship between the speed of transmission of the pulse wave (which must be distinguished from the speed of flow of blood) and the elastic properties of the arterial wall has been studied extensively, both from a theoretical point of view. only from an experimental point of view.
- the speed of the pulse wave is proportional to the square root of the Young's elastic modulus of the material constituting the wall (Moens-Korteweg equation).
- ⁇ L distance separating the two measurement points
- ⁇ t time shift of the two waves
- dP time derivative of the blood pressure
- p density of the blood
- V initial arterial volume
- dV temporal derivative of the arterial volume
- VOP pulse wave
- the contraction of the left ventricle generates a pressure wave and deformation of the arterial wall which propagates from the heart to the periphery at a finite speed, proportional to the square root of the stiffness of the wall.
- Many mathematical models have been developed, and can be summarized by the Bramwell and Hill equation (see equation 1).
- the measurements of VOP can be based on the transit time of the pressure wave, the flow wave or the deformation wave in an equivalent manner. Two points are major:
- the aim is to obtain the most precise arterial waves possible, especially in the frequency domain. Indeed, the determination of the VOP is most often done at the "bottom of the wave", that is to say in diastole. It is the moment of the cardiac cycle when the waves are richest in components of high frequency. Any damping of the collected waves results in a lack of precision in determining the foot of the wave.
- the ideal sensors due to their high fidelity are piezoelectric quartz mechanotransducers, of the same type as those used for aplanation tonometry. Less expensive mechanotransducers are also routinely used, whose frequency response characteristics are compatible with the objectives "(bandwidth 0.1 to 100 Hz).
- the ease with which the wave bottom is readable depends on the frequency response of the transducer, and the quality of the signal. It is obvious that the use of algorithms cannot fully compensate for poor quality signals. Whether working manually (by the tangent method), or with computerized techniques, it is essential to obtain pressure waves of the best possible quality.
- the use of techniques automatic analysis of the pulse wave, as implemented in the Complior device (Colson, Les Lilas, France) is an important guarantee of reproducibility in the measurements.
- the measurement of the length traveled by the pressure wave is the weak link in the non-invasive measurement of arterial stiffness by VOP, which is particularly sensitive for the speed of the carotid-femoral pulse. Indeed, it is necessary to estimate the length traveled by the pressure wave between the two measurement sites.
- the inhomogeneity of the underlying arterial tree is a frequently criticized criticism of the speed of the carotid-femoral pulse wave.
- the great interest of the carotido-femoral VOP is that it takes into account most of the compliance arteries globally. However, this quantity takes into account several arterial segments of different structure, and where the pulse wave propagates in opposite directions. In the anterograde direction, we see the thoracic aorta (pure elastic), the abdominal aorta (musculo-elastic), the primitive iliacs, then the external iliacs, finally the common femoral (muscular). The brachiocephalic arterial trunk, then the right common carotid artery are traversed in the retrograde direction.
- the propagation of the pressure wave takes place from the heart towards the periphery at the speed corresponding to the speed of the pulse wave. Then, the pressure wave is reflected on the peripheral reflection sites, and returns to the heart. Given the speed of the pulse wave, which is around 10-15 m / second, and the distance covered, the reflected wave will be able to add to the incident wave, sooner or later in the cardiac systole.
- FIG. 2 represents a pressure wave of type A, characteristic of an elderly, hypertensive patient.
- FIG. 3 represents a pressure wave of type C, characteristic of a young and in good shape patient.
- ⁇ P The relationship between ⁇ P and PP is called the increase index.
- ⁇ tp is the time towards the shoulder.
- the ventricular ejection time is called LVET (for "left ventricle ejection time” in English).
- Pi is the pressure at the inflection point.
- the magnitude of the pressure drawn and the index of increase are direct estimates of the intensity of the reflection wave.
- the time towards the shoulder assesses the distance from the reflection. Finally, the ventricular ejection time is indicative in itself.
- the techniques available for this type of study are all based on the applanation tonometry.
- the pressure signal collection site and the signal analysis techniques make the difference.
- the pressure wave should be collected as close as possible to the aortic valves.
- Non-invasively, the carotid pressure wave is a good compromise.
- the analysis of pressure traces can be manual (on traces), or digitized.
- the advantage of the augmentation index is its non-dimensionality (cutting short all calibration problems).
- FIG. 4 is a schematic representation of the incident wave 1 and the reflected wave 2.
- the summation of the two wave trains determines the morphology of the pressure wave observed. In the case of subjects with very distensible arteries, the summation is done in diastole (case of curve 3). If the arteries are rigid, the summation takes place during systole and increases the pressure accordingly (see curve 4).
- a peripheral pressure tracing like the radial artery
- Such a transfer function has been established in a normal reference population. It works reasonably well for comparable populations, but nothing guarantees the extrapolation of this transfer function to sick populations. Based on this principle, a device has been marketed under the brand name Sphygmocor (PWV Medical, Sydney, Australia).
- the existing devices are prototypes or are small series and dedicated to clinical research, have a unique function and are high cost.
- the present invention has been designed to remedy the drawbacks of the prior art.
- a first object of the invention consists of a blood pressure microsensor comprising means for holding and positioning, on the palm surface of a practitioner's finger, a pellet of piezoresistive material, the dimensions of the pellet being smaller than the diameter of the artery whose pressure is to be measured, the microsensor also comprising means for transmitting the electrical signal supplied by the piezoresistive pellet in response to a pressure to which the pellet is subjected.
- the means for holding and positioning the pellet of piezo-resistive material consist of a thermowell on which the pellet is fixed.
- a second object of the invention consists of an apparatus for measuring arterial rigidity comprising: - a first arterial pressure microsensor as defined above, allowing a measurement of blood pressure at a first determined location on a patient's body,
- a second arterial pressure microsensor as defined above, allowing a measurement of the arterial pressure at a second determined location in the body of a patient different from the first determined location
- a processing and calculation device receiving as input the electrical signals delivered by the first and second pressure microsensors and information relating to the length, from a point of view of arterial circulation, between the first determined location and the second determined location, the device having calculation means making it possible to calculate, from electrical signals and information received as input, the velocity of the patient's pulse wave and to deduce therefrom the arterial stiffness of the patient.
- the determined locations correspond to the primary carotid artery at the level of the neck and to the common femoral artery at the level of the fold of the groin.
- the device may also have evaluation means providing an indication of the risk factors for a patient's cardiovascular accidents as a function of the inferred arterial stiffness, as well as other risk factors.
- FIG. 4 is a schematic representation, for blood pressure, of an incident wave and a reflected wave
- FIG. 5 shows a pellet of piezoresistive material, maintained and positioned on a thermowell and forming part of the arterial pressure microsensor according to the invention
- FIG. 6 shows an apparatus for measuring arterial stiffness according to the invention.
- FIG. 5 shows a pellet of piezoresistive material 10, maintained and positioned on a thermowell 11 placed on a practitioner's finger. Electrical conductors 12 electrically connect the pellet of piezoresistive material to an apparatus of the electrical signals transmitted by the chip.
- the patch 10 has dimensions smaller than the diameter of the artery whose pressure is to be measured.
- the material of the pellet is for example of the piezoresistive type.
- the patch makes it possible to obtain a very small measurement area (approximately 2 mm), which makes it possible to obtain a very precise location of the point to be measured. Any significant difference between the measurement point and the point to be measured leads to a significant attenuation of the signal collected.
- the microsensor of the invention simultaneously combines electronic measurement and fine palpation of the pulse by the practitioner. It measures the support surface pulse and the deep pulse by manually controlling the support force.
- the microsensor of the invention induces a very small deformation of the artery to be measured, unlike the sensors currently used. There is therefore no significant disturbance of the fluid mechanics in the artery to be measured.
- the microsensor according to the invention allows measurements of pulse at locations of the body that are difficult to measure by the sensors of the prior art.
- the possible insertion of the sensor pad into a thermowell makes measurement easier.
- the tablet can be inside or outside the thermowell. Its installation can be done by deposit.
- the tablet can also be overmolded to obtain a hard part allowing good localization.
- FIG. 6 represents an apparatus for measuring arterial rigidity according to the invention comprising a processing and calculation device 20, receiving as input the electrical signals delivered by a first and a second arterial pressure microsensor.
- the first microsensor comprises a first pellet 30 of piezoresistive material connected by electrical conductors 31 to the device 20.
- the second microsensor comprises a second pellet 40 of piezoresistive material connected by electrical conductors 41 to the device 20.
- the first microsensor is for example intended to measure the pressure of the primary carotid artery at the level of the neck.
- the second microsensor is for example intended to measure the pressure of the common femoral artery at the level of the groin fold.
- the processing and calculating device 20 also receives information relating to the length, from a point of view of arterial circulation, between the two pressure measurement points. It has computing means for calculating the velocity of a patient's pulse wave from the data entered by its inputs. It then provides a value for the patient's arterial stiffness.
- the electrical signals transmitted by the microsensors can be, at the input of the device 20, shaped to be used by a digital acquisition system connected to a system computer science.
- This computer system can be small or be coupled to a laptop or any other signal processing or transmission device.
- the measurement of the pulse wave speed can be coupled with the analysis of the carotid pulse wave.
- the measurement of the distance between the two measurement points can be greatly facilitated and improved by the use of a joint ultrasonic sensor.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Physiology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0302342A FR2851449B1 (fr) | 2003-02-26 | 2003-02-26 | Microcapteur de pression arterielle et appareil de mesure l'utilisant |
FR0302342 | 2003-02-26 | ||
PCT/FR2004/050073 WO2004075744A1 (fr) | 2003-02-26 | 2004-02-23 | Microcapteur de pression arterielle et appareil de mesure l'utilisant |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1596713A1 true EP1596713A1 (fr) | 2005-11-23 |
Family
ID=32799597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04713570A Withdrawn EP1596713A1 (fr) | 2003-02-26 | 2004-02-23 | Microcapteur de pression arterielle et appareil de mesure l`utilisant |
Country Status (5)
Country | Link |
---|---|
US (1) | US20060079791A1 (fr) |
EP (1) | EP1596713A1 (fr) |
JP (1) | JP2006519045A (fr) |
FR (1) | FR2851449B1 (fr) |
WO (1) | WO2004075744A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2309668C1 (ru) | 2006-02-20 | 2007-11-10 | Александр Сергеевич Парфенов | Способ неинвазивного определения функции эндотелия и устройство для его осуществления |
CN102170821B (zh) * | 2008-10-01 | 2013-08-07 | 株式会社Irumedi | 心血管分析装置 |
US8057400B2 (en) | 2009-05-12 | 2011-11-15 | Angiologix, Inc. | System and method of measuring changes in arterial volume of a limb segment |
US20110208071A1 (en) * | 2010-02-24 | 2011-08-25 | National Taiwan University | SMART NON-INVASIVE ARRAY-BASED HEMODYNAMIC MONITORING SYSTEM on CHIP AND METHOD THEREOF |
JP5636731B2 (ja) * | 2010-05-10 | 2014-12-10 | オリンパス株式会社 | 血圧センサシステム及びその血圧計測方法 |
WO2013108361A1 (fr) * | 2012-01-17 | 2013-07-25 | 株式会社日立製作所 | Système de mesure de la pression veineuse |
ITMN20120007A1 (it) * | 2012-04-18 | 2013-10-19 | Roberto Agosta | Manometro arteriografico emodinamico per mezzo di macro sensori cutanei di carico piezoelettrici. una tecnologia innovativa per il rilievo ad elevata precisione dei valori di pressione arteriosa sistemica e dei parametri di funzione cardiaca ed aorti |
JP6344725B2 (ja) * | 2013-05-24 | 2018-06-20 | 国立大学法人浜松医科大学 | 触診用近赤外酸素濃度センサ |
US10588521B2 (en) | 2013-07-10 | 2020-03-17 | Hitachi, Ltd. | Sphygmomanometer system |
CN104398246B (zh) * | 2014-12-17 | 2016-07-27 | 电子科技大学 | 一种基于柔性传感器检测人体血压的指环式芯片 |
FR3053236A1 (fr) * | 2016-07-01 | 2018-01-05 | Bodycap | Dispositif de mesure d'une contrainte mecanique ou d'un mouvement. |
KR102517692B1 (ko) | 2018-02-05 | 2023-04-03 | 삼성전자주식회사 | 혈압 측정 장치 및 방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4144877A (en) * | 1976-08-12 | 1979-03-20 | Yeda Research And Development Co. Ltd. | Instrument for viscoelastic measurement |
US4269193A (en) * | 1977-11-04 | 1981-05-26 | Sri International | Noninvasive blood pressure monitoring transducer |
US4338950A (en) * | 1980-09-22 | 1982-07-13 | Texas Instruments Incorporated | System and method for sensing and measuring heart beat |
US4802488A (en) * | 1986-11-06 | 1989-02-07 | Sri International | Blood pressure monitoring method and apparatus |
US4799491A (en) * | 1986-11-06 | 1989-01-24 | Sri International | Blood pressure monitoring method and apparatus |
US5012817A (en) * | 1989-05-19 | 1991-05-07 | University Of Victoria | Dolorimeter apparatus |
US5503156A (en) * | 1994-03-11 | 1996-04-02 | Millar Instruments, Inc. | Noninvasive pulse transducer for simultaneously measuring pulse pressure and velocity |
US7544168B2 (en) * | 2004-09-30 | 2009-06-09 | Jerusalem College Of Technology | Measuring systolic blood pressure by photoplethysmography |
-
2003
- 2003-02-26 FR FR0302342A patent/FR2851449B1/fr not_active Expired - Fee Related
-
2004
- 2004-02-23 EP EP04713570A patent/EP1596713A1/fr not_active Withdrawn
- 2004-02-23 JP JP2006502179A patent/JP2006519045A/ja active Pending
- 2004-02-23 WO PCT/FR2004/050073 patent/WO2004075744A1/fr active Search and Examination
- 2004-02-23 US US10/546,039 patent/US20060079791A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO2004075744A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20060079791A1 (en) | 2006-04-13 |
JP2006519045A (ja) | 2006-08-24 |
WO2004075744A1 (fr) | 2004-09-10 |
FR2851449B1 (fr) | 2005-12-02 |
FR2851449A1 (fr) | 2004-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Woodman et al. | Assessment of central and peripheral arterial stiffness: studies indicating the need to use a combination of techniques | |
Salvi et al. | Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the PulsePen device | |
Joseph et al. | Technical validation of ARTSENS–An image free device for evaluation of vascular stiffness | |
Hsu et al. | Skin-coupled personal wearable ambulatory pulse wave velocity monitoring system using microelectromechanical sensors | |
TWI250867B (en) | Pulse wave analysis device | |
BE1024423B1 (fr) | Equipement de surveillance des flux sanguins et respiratoires | |
EP2994043B1 (fr) | Appareil et procede de determination de la vitesse de propagation d'une onde de pouls | |
TW201728307A (zh) | 用於估計血壓和其他心血管性質的超聲波設備 | |
Sharma et al. | Acoustic sensing as a novel wearable approach for cardiac monitoring at the wrist | |
EP1060705A1 (fr) | Procédé de détermination de la vitesse d'une onde de pouls et d'estimation de la pression aortique | |
WO2004075744A1 (fr) | Microcapteur de pression arterielle et appareil de mesure l'utilisant | |
FR2894450A1 (fr) | Dispositif et procede de mesure non invasive de la pression sanguine | |
JP2013544576A (ja) | 少なくとも1つの血管内部の血圧を測定するための装置、システム、および方法 | |
Joseph et al. | Arterial compliance probe for cuffless evaluation of carotid pulse pressure | |
CN103505191B (zh) | 一种利用压脉带的压力脉波震荡讯号以预估中心主动脉脉搏压的方法及其装置 | |
Guo et al. | Piezoelectric sensor for the monitoring of arterial pulse wave: Detection of arrhythmia occurring in PAC/PVC patients | |
EP0681447B1 (fr) | Dispositif de determination d'informations physiologiques, et utilisation correspondante | |
Van Velzen et al. | Comparison between pulse wave velocities measured using Complior and measured using Biopac | |
Bikia | Non-invasive monitoring of key hemodynamical and cardiac parameters using physics-based modelling and artificial intelligence | |
WO2015173785A1 (fr) | Methode d'evaluation continue du couplage ventriculo-aortique de patients a risque, par analyse de boucles pression-flux | |
EP3294121A1 (fr) | Procede et dispositif de determination de parametres representatifs d'une activite cardiovasculaire | |
Tu et al. | Optimal design of a new strain-type sensor for cuff-less blood pressure measurement via finite element modeling and taguchi method | |
Hanboly | Arterial stiffness in health and disease | |
EP2378962B1 (fr) | Procede de mesure d'un indice de la rigidite locale de la paroi d'une artere de conduction et installation correspondante | |
Hasan et al. | An evaluation of the accelerometer output as a motion artifact signal during photoplethysmograph signal processing control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050816 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M Owner name: COMMISSARIAT A L'ENERGIE ATOMIQUE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M Owner name: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140902 |